Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3 - Hallo friend NEWS AN INSPIRATION, In the article you read this time with the title Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3, we have prepared well for this article you read and download the information therein. hopefully fill posts Article ECONOMY, Article HEALTH, Article POLITICS, Article SPORTS, Article TRAVELING, Article UPDATE, we write can understand. Well, happy reading.

Titre : Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3
link : Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3

Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3

SOF/VEL and Resistance-associated Substitutions in HCV GT3

Alimentary Pharmacology & Therapeutics, June 21, 2018
J. von Felden; J. Vermehren; P. Ingiliz; S. Mauss; T. Lutz; K. G. Simon; H. W. Busch; A. Baumgarten; K. Schewe; D. Hueppe; C. Boesecke; J. K. Rockstroh; M. Daeumer; N. Luebke; J. Timm; J. Schulze zur Wiesch; C. Sarrazin; S. Christensen

Does the presence of resistance-associated substitutions impact the efficacy of therapy with sofosbuvir/velpatasvir with or without ribavirin in patients with HCV genotype 3?
Medscape - Full Text

Abstract and Introduction
Abstract
Background Twelve weeks of the pangenotypic direct–acting antiviral (DAA) combination sofosbuvir/velpatasvir (SOF/VEL) was highly efficient in patients with hepatitis C virus (HCV) genotype 3 (GT3) infection in the ASTRAL–3 approval study. However, presence of resistance–associated substitutions (RASs) in the HCV nonstructural protein 5A (NS5A) was associated with lower treatment response.

Aim To assess the efficacy and safety of SOF/VEL ± ribavirin (RBV) and the impact of NS5A RASs and RBV use on treatment outcome in HCV GT3 infection in a real–world setting.

View Full Article...…..

Free registration may be required.

Thus articles Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3

that is all articles Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3 This time, hopefully can provide benefits to you all. Okay, see you in another article post.

You are now reading the article Sofosbuvir/velpatasvir and Resistance-associated Substitutions in HCV genotype 3 the link address https://newsaninpiration.blogspot.com/2018/06/sofosbuvirvelpatasvir-and-resistance.html

Tweet

Subscribe to receive free email updates: